Eterna Therapeutics Inc
NASDAQ:ERNA

Watchlist Manager
Eterna Therapeutics Inc Logo
Eterna Therapeutics Inc
NASDAQ:ERNA
Watchlist
Price: 1.28 USD -2.29% Market Closed
Market Cap: 10m USD

Operating Margin
Eterna Therapeutics Inc

-6 747.5%
Current
-9 391%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-6 747.5%
=
Operating Profit
-32.9m
/
Revenue
488k

Operating Margin Across Competitors

No Stocks Found

Eterna Therapeutics Inc
Glance View

Market Cap
9.6m USD
Industry
Biotechnology

Eterna Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Brooklyn, New York and currently employs 10 full-time employees. Eterna Therapeutics Inc., formerly Brooklyn ImmunoTherapeutics Inc., is a clinical-stage biopharmaceutical company. The firm is focused on developing cytokine-based therapies for treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Its lead product candidate, IRX-2, is a cytokine therapy, to treat patients with head and neck cancer. IRX-2 is a mixed, human-derived cytokine product with multiple active constituents including Interleukin-2 (IL2) and other key cytokines, which restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. The firm also has multiple cell and gene-editing therapies in preclinical development for various indications, including acute respiratory distress syndrome, solid tumor indications, as well as in vivo gene-editing therapies for rare genetic diseases. Its subsidiaries include Brooklyn ImmunoTherapeutics LLC, Novellus, Inc. and Novellus Therapeutics, Ltd.

ERNA Intrinsic Value
0.81 USD
Overvaluation 37%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-6 747.5%
=
Operating Profit
-32.9m
/
Revenue
488k
What is the Operating Margin of Eterna Therapeutics Inc?

Based on Eterna Therapeutics Inc's most recent financial statements, the company has Operating Margin of -6 747.5%.

Back to Top